Accessible Search Form           Advanced Search

  • PRINT PAGE  |  PRINT ENTIRE TOPIC  |  SHARE

Links to Other Information About Idiopathic Pulmonary Fibrosis

NHLBI Resources

Non-NHLBI Resources

Clinical Trials

Rate This Content:

  
previous topic
Idiopathic Pulmonary Fibrosis Clinical Trials

Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Idiopathic Pulmonary Fibrosis, visit www.clinicaltrials.gov.


Idiopathic Pulmonary Fibrosis in the News

May 19, 2014
Common treatment for patients with chronic, progressive lung disease found to be ineffective
A drug used to treat patients with mild to moderate lung damage from the disease idiopathic pulmonary fibrosis (IPF) is no better than placebo for preserving lung function, according to a study supported by the National Institutes of Health. The finding is in the final report of a clinical trial called Prednisone, Azathioprine, and N-Acetylcysteine: A Study That Evaluates Response in Idiopathic Pulmonary Fibrosis (PANTHER-IPF).

View all Idiopathic Pulmonary Fibrosis Press Releases

 
September 20, 2011 Last Updated Icon

The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.